MPs launch inquiry into UK asthma outcomes
Improvements in key asthma outcomes have stalled in the last decade
Read More
Tag: MPs
UK’s coronavirus testing capacity has been ‘inadequate’, Committee finds
A 19-page letter to the Prime Minister details ten key lessons the UK government should learn from its experience of handling the pandemic so far
Read More
“Prevention more important than cure”, say MPs on NHS
49% of MPs said that they are confident that the NHS Long Term Plan will be successful in improving the prevention of ill health and disease.
Read More
Campaigners call for NHS access to Orkambi as MP inquiry gets underway
Patients and campaigners took to the streets in London yesterday demanding NHS access to Vertex’ cystic fibrosis drugs, following a public hearing on the situation ordered by MPs.
Read More
MPs voice concern over clinical trials transparency
MPs have expressed concern that nearly half of clinical trials in the UK fail to publish their results, “presenting risks to human health and increasing research wastage”.
Read More
MPs vote for UK to remain part of EMA
MPs have voted 305-301 that the UK should negotiate to remain part of the European Medicines Agency following Brexit.
Read More
Ministers write letter to Vertex over Orkambi debate
Ministers from the Department of Health have written a letter asking that Vertex bring negotiations with NHS England over access to cystic fibrosis drug Orkambi “to an urgent resolution”.
Read More
MPs slate rate of progress on NHS cyber security
MPs have criticised the government’s slow response to last year’s WannaCry attack on the NHS, and warn there is much work to be done to improve cyber security if damage from the next attack is to be minimised.
Read More
MPs call on government to help with Orkambi debate
MPs are calling on NHS England and Vertex to come to an agreement over the price of cystic fibrosis drug Orkambi.
Read More
A&E departments under-resourced, MPs believe
Just 33 percent of MPs believe emergency departments have sufficient resources to keep patients safe, shows a new poll by the Royal College of Emergency Medicine.
Read More
- Cure Parkinson’s convenes expert panel to assess £2 million combination therapy funding call
- Kygevvi approved in Europe as first treatment for TK2d
- Tozorakimab shows significant benefit in two major COPD trials
- Daratumumab becomes first oncology injectable approved for patient administration
- Laigo Bio completes final close of €17m seed financing round
